Kenneth H. Cowan
Director
Oncology
Cancer Research Technology
Australia
Biography
Cancer research continues to move toward precision cancer medicine. Using genomics and other new diagnostic tools, we will be able to employ precision medicine to customize therapies, care for each cancer patient individually, and ultimately improve outcomes. We are investing more efforts into personalized treatments. Also, our translational science is well developed now with a team of scientists solely devoted to researching cancer and drug development. It is spurring new and innovative approaches to prevention, early detection, diagnosis, and treatment of cancer. In 2017, when we open the new cancer center, it will look even better as we will have lab scientists and clinical providers in one single location that is designed to spark collaboration and discovery. We also are working with all of the Big Ten CRC institutions to develop investigator-initiated early phase clinical trials and develop collaborative research programs.
Research Interest
Cancer Research
